Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes

Journal of Virology

Volumn 86, Issue 18, 2012, Pages 9952-9963

  Moss, Nicholas J ^a,d   Magaret, Amalia ^a,b   Laing, Kerry J ^a,b   Kask, Angela Shaulov ^a   Wang, Minna ^a   Mark, Karen E ^a,b,e   Schiffer, Joshua T ^a,b   Wald, Anna ^a,b   Koelle, David M ^a,b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d HIV Prevention Section   (United States)

^e Office of AIDS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; RECURRENT INFECTION; VIRUS SHEDDING;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; COHORT STUDIES; CYTOKINES; CYTOMEGALOVIRUS INFECTIONS; DENDRITIC CELLS; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; VIRUS SHEDDING; YOUNG ADULT;

CYTOMEGALOVIRUS; HERPES; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 84866152540     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00829-12     Document Type: Article

References (69)

1. Abbo L, et al. 2007. Selective defect in plasmacyoid dendritic cell function in a patient with AIDS-associated atypical genital herpes simplex vegetans treated with imiquimod. Clin. Infect. Dis. 44:e25-e27.
2. Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM. 2000. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus and cytomegalovirus determined by intracellular detection of cytokine expression. J. Infect. Dis. 181:859-866.
3. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. 1988. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 26:662-667.
4. Belshe RB, et al. 2012. Efficacy results of a trial of a herpes simplex vaccine. N. Engl. J. Med. 366:34-43.
5. Bochud PY, Magaret AS, Koelle DM, Aderem A, Wald A. 2007. Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus type 2 infection. J. Infect. Dis. 196:505-509.
6. Burchett SK, et al. 1992. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J. Infect. Dis. 165:813-818.
7. Casazza JP, et al. 2006. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J. Exp. Med. 203:2865-2877.
8. Chentoufi AA, et al. 2008. Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B. J. Virol. 82:11792-11802.
9. Corey L, Reeves WC, Holmes KK. 1978. Cellular immune response in genital herpes simplex virus infection. N. Engl. J. Med. 299:986-991.
10. Corey L, Wald A. 2008. Genital herpes, p 399-437. In Holmes KK, et al. (ed), Sexually transmitted diseases. McGraw Hill Medical, New York, NY.
11. Cunningham AL, Merigan TC. 1983. Gamma interferon production appears to predict time of recurrence of herpes labialis. J. Immunol. 130: 2397-2400.
12. Derhovanessian E, Larbi A, Pawelec G. 2009. Biomarkers of human immunosenescence: impact of cytomegalovirus infection. Curr. Opin. Immunol. 21:440-445.
13. Diggle PJ, Heagerty PJ, Liang KY, Zeger SL. 2002. Analysis of longitudinal data. Oxford University Press, Oxford, United Kingdom.
14. Donaghy H, et al. 2009. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J. Virol. 83:1952-1961.
15. Feldman SB, et al. 1994. Viral induction of low frequency interferonalpha producing cells. Virology 204:1-7.
16. Gebhardt T, et al. 2009. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 10:524-530.
17. Gebhardt T, et al. 2011. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 477:216-219.
18. Gonzalez JC, Kwok WW, Wald A, McClurkan CL, Koelle DM. 2005. Programmed expression of cutaneous lymphocyte-associated antigen amongst circulating memory T-cells specific for HSV-2. J. Infect. Dis. 191:243-254.
19. Green JA, Weiss PN, Yeh TJ, Spruance SL. 1985. Immune-specific interferon production by peripheral blood mononuclear leukocytes from patients with primary and recurrent oro-labial herpes simplex virus infections. J. Med. Virol. 16:297-305.
20. Harari A, Vallelian F, Meylan PR, Pantaleo G. 2005. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 174:1037-1045.
21. Harari A, Vallelian F, Pantaleo G. 2004. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur. J. Immunol. 34:3525-3533.
22. Hultin LE, et al. 2010. Comparison of interlaboratory variation in absolute T-cell counts by single-platform and optimized dual-platform methods. Cytometry B Clin. Cytom. 78:194-200.
23. Ida JA, et al. 2006. A whole blood assay to assess peripheral blood dendritic cell function in response to Toll-like receptor stimulation. J. Immunol. Methods 310:86-99.
24. Jerome KR, Huang ML, Wald A, Selke S, Corey L. 2002. Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR. J. Clin. Microbiol. 40:2609-2611.
25. Jing L, et al. 2012. Herpes simplex virus type 1 T-cells antigens in humans revealed by cross-presentation and genome-wide screening. J. Clin. Invest. 122:654-673.
26. Khan N, et al. 2004. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J. Immunol. 173:7481-7489.
27. Kittan NA, et al. 2007. Impaired plasmacytoid dendritic cell innate immune responses in patients with herpes virus-associated acute retinal necrosis. J. Immunol. 179:4219-4230.
28. Koch S, et al. 2007. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann. N. Y. Acad. Sci. 1114:23-35.
29. Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L. 1994. Direct recovery of HSV-specific T lymphocyte clones from human recurrent HSV-2 lesions. J. Infect. Dis. 169:956-961.
30. Koelle DM, et al. 1994. Antigenic specificity of human CD4+ T cell clones recovered from recurrent genital HSV-2 lesions. J. Virol. 68:2803-2810.
31. Koelle DM, et al. 1998. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 101:1500-1508.
32. Koelle DM, et al. 2000. Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. J. Virol. 74:10930-10938.
33. Koelle DM, Schomogyi M, McClurkan C, Reymond SN, Chen HB. 2000. CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins. J. Virol. 74:11422-11425.
34. Laing KJ, et al. 2010. Diversity in CD8(+) T cell function and epitope breadth among persons with genital herpes. J. Clin. Immunol. 30:703-722.
35. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. 2003. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513-520.
36. Magaret AS, Wald A, Huang ML, Selke S, Corey L. 2007. Optimizing PCR positivity criterion for detection of herpes simplex virusDNAon skin and mucosa. J. Clin. Microbiol. 45:1618-1620.
37. Mark KE, et al. 2007. Topical Resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial. J. Infect. Dis. 195:1324-1331.
38. McKenna DB, Neill WA, Norval M. 2001. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences. Br. J. Dermatol. 144:459-464.
39. Netea MG, Wijmenga C, O'Neill LA. 2012. Genetic variation in Toll-like receptors and disease susceptibility. Nat. Immunol. 13:535-542.
40. Neter J, Wasserman W, Kutner MH. 1990. Applied linear statistical models, 3rd ed. Irwin Press, Homewood, IL.
41. Perez de Diego R, et al. 2010. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33:400-411.
42. Posavad CM, Koelle DM, Shaughnessy MF, Corey L. 1997. Severe genital herpes infections in HIV-infected individuals with impaired HSVspecific CD8+ cytotoxic T lymphocyte responses. Proc. Natl. Acad. Sci. U. S. A. 94:10289-10294.
43. Pourgheysari B, et al. 2007. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J. Virol. 81:7759-7765.
44. Rasmussen LE, Jordan GW, Stevens DA, Merigan TC. 1974. Lymphocyte interferon production and transformation after herpes simplex infections in humans. J. Immunol. 112:728-736.
45. Sancho-Shimizu V, et al. 2011. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J. Clin. Invest. 121:4889-4902.
46. Sato A, Linehan MM, Iwasaki A. 2006. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 103:17343-17348.
47. Schmid DS, Thieme ML, Gary HE, Reeves WC. 1997. Characterization of T cell responses to herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) using a TNF-beta ELISpot cytokine assay. Arch. Virol. 142:1659-1671.
48. Schuster P, et al. 2010. Co-ordinated regulation of plasmacytoid dendritic cell surface receptors upon stimulation with herpes simplex virus type 1. Immunology 129:234-247.
49. Siegal FP, et al. 1999. The nature of the principle type 1 interferonproducing cells in human blood. Science 284:1835-1837.
50. Solomon L, et al. 2003. Epidemiology of recurrent genital herpes simplex virus types 1 and 2. Sex. Transm. Infect. 79:456-459.
51. Sorensen LN, et al. 2008. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J. Immunol. 181:8604-8612.
52. Spruance SL, et al. 1995. Th1/Th2-like immunity and resistance to herpes simplex labialis. Antiviral Res. 28:39-55.
53. Spruance SL, Kriesel JD, Evans TG, McKeough MB. 1995. Susceptibility to herpes labialis following multiple experimental exposures to ultraviolet radiation. Antiviral Res. 28:57-67.
54. Sylwester AW, et al. 2005. Broadly targeted human cytomegalovirusspecific CD4+and CD8+T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202:673-685.
55. Tassone L, et al. 2010. Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients. Blood 116:4870-4873.
56. Tomasini D, et al. 2010. Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner's lymphocytic infiltrate of the skin and cutaneous lupus erythematosus. J. Cutan. Pathol. 37:1132-1139.
57. Tronstein E, et al. 2011. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 305:1441-1449.
58. Vescovini R, et al. 2007. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J. Immunol. 179:4283-4291.
59. Vestey JP, Norval M, Howie S, Maingay J, Neill WA. 1989. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections. Clin. Exp. Immunol. 77:384-390.
60. Wakim LM, Waithman J, van Rooijen N, Heath WR, Carbone FR. 2008. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 319:198-202.
61. Wald A, Huang ML, Carrell D, Selke S, Corey L. 2003. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J. Infect. Dis. 188:1345-1351.
62. Wald A, et al. 2011. Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons. Vaccine 29: 8520-8529.
63. Wald A, et al. 2000. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N. Engl. J. Med. 342:844-850.
64. Yang CA, et al. 2012. Association of TLR3-hyporesponsiveness and functional TLR3 L412F polymorphism with recurrent herpes labialis. Hum. Immunol. 73:844-851
65. Yasukawa M, Zarling JM. 1984. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens. J. Immunol. 133:422-427.
66. Yoneyama H, et al. 2005. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J. Exp. Med. 202:425-435.
67. Zhang SY, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-1527.
68. Zhu J, et al. 2009. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15:886-892.
69. Zhu J, et al. 2007. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J. Exp. Med. 204:595-603.